Neuroimaging Studies of Effects of Psychotherapy in Depression

doi:10.1017/9781108623018.021

Chapter 20 - Neuroimaging Studies of Effects of Psychotherapy in Depression

from Section 5 - Therapeutic Applications of Neuroimaging in Mood Disorders

Published online by Cambridge University Press: 12 January 2021

Isabelle E. Bauer and

Edited by

Paolo Brambilla and

Sudhakar Selvaraj: Affiliation:
UTHealth School of Medicine, USA
Paolo Brambilla: Affiliation:
Università degli Studi di Milano
Jair C. Soares: Affiliation:
UT Harris County Psychiatric Center, USA

Book contents

Get access

Summary

Depression is one of the leading causes of mortality, disability, and loss of productivity. The World Health Organization (WHO) ranks depressive disorders as the eleventh cause of disability and mortality (1, 2). The worldwide lifetime prevalence of depression is around 12% (3). In spite of the considerable burden of depression both in terms of prevalence and public health impact, the search for more effective treatments for depression is still ongoing. Emerging evidence suggests that personalizing treatments based on individuals’ biosignature could be the “way forward” (4).

Type: Chapter
Information: Mood Disorders
Brain Imaging and Therapeutic Implications
, pp. 261 - 272

DOI: https://doi.org/10.1017/9781108623018.021 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Whiteford, HA, et al. Global burden of disease attributable to mental and substance use disorders: Findings from the global burden of disease study 2010. Lancet. 2013; 382(9904): 1575–1586.Google Scholar

Park, SC, et al. Does age at onset of first major depressive episode indicate the subtype of major depressive disorder?: The clinical research center for depression study. Yonsei Med J. 2014; 55(6): 1712–1720.Google Scholar

Kessler, RC, et al. Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: Results from the WHO world mental health survey initiative. Depress Anxiety. 2010; 27(4): 351–364.Google Scholar

Oquendo, MA. McGrath, P, Weissman, MM. Biomarker studies and the future of personalized treatment for depression. Depression and Anxiety. 2014; 31(11): 902–905.CrossRef Google Scholar PubMed

Chen, C-H, et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biological Psychiatry. 2007; 62(5): 407–414.Google Scholar

Li, C-T, et al. Cognition-modulated frontal activity in prediction and augmentation of antidepressant efficacy: A randomized controlled pilot study. Cerebral Cortex. 2014; 26(1): 202–210.Google Scholar

Cuijpers, P, et al. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: A meta-analysis. Journal of Affective Disorders. 2014; 159: 118–126.Google Scholar

Cuijpers, P, et al. Psychological treatment of depression: A meta-analytic database of randomized studies. BMC Psychiatry. 2008; 8(1): 36.Google Scholar

Cuijpers, P, et al. A meta-analysis of cognitive-behavioural therapy for adult depression, alone and in comparison with other treatments. The Canadian Journal of Psychiatry. 2013; 58(7): 376–385.CrossRef Google Scholar PubMed

Karyotaki, E, et al. Combining pharmacotherapy and psychotherapy or monotherapy for major depression? A meta-analysis on the long-term effects. Journal of Affective Disorders. 2016; 194: 144–152.Google Scholar

Cuijpers, P, et al. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: A meta‐analysis. World Psychiatry. 2014; 13(1): 56–67.Google Scholar

Chakrabarty, T, Ogrodniczuk, J, Hadjipavlou, G. Predictive neuroimaging markers of psychotherapy response: A systematic review. Harvard Review of Psychiatry. 2016; 24(6): 396–405.Google Scholar

Linden, D. How psychotherapy changes the brain–the contribution of functional neuroimaging. Molecular Psychiatry, 2006. 11(6): 528.Google Scholar

Frewen, PA, Dozois, DJ, Lanius, RA. Neuroimaging studies of psychological interventions for mood and anxiety disorders: empirical and methodological review. Focus. 2010; 8(1): 92–109.Google Scholar

Beauregard, M. Functional neuroimaging studies of the effects of psychotherapy. Dialogues in Clinical Neuroscience. 2014; 16(1): 75.CrossRef Google Scholar PubMed

Barsaglini, A, et al. The effects of psychotherapy on brain function: A systematic and critical review. Progress in Neurobiology. 2014; 114: 1–14.Google Scholar

Roffman, JL, et al. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychological Medicine. 2005; 35(10): 1385–1398.Google Scholar

Fu, C, Steiner, H, Costafreda, SG. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Disease. 2013. 52: 75–83.Google Scholar

Beck, JS. Cognitive Behavior Therapy: Basics and Beyond. Guilford press; 2011.Google Scholar

Parker, G, Fletcher, K. Treating depression with the evidence‐based psychotherapies: A critique of the evidence. Acta Psychiatrica Scandinavica. 2007; 115(5): 352–359.CrossRef Google Scholar PubMed

Beck, AT. Cognitive Therapy of Depression. Guilford press; 1979.Google Scholar

Crowther, A, et al. Resting-state connectivity predictors of response to psychotherapy in major depressive disorder. Neuropsychopharmacology. 2015; 40(7): 1659–1673.Google Scholar

Dimidjian, S, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology. 2006; 74(4): 658.Google Scholar

Dobson, KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Journal of Consulting and Clinical Psychology. 2008; 76(3): 468.Google Scholar

Klerman, GL, et al. Interpersonal Psychotherapy for Depression. Lanham, Maryland, USA: Rowman & Littlefield; 1996.Google Scholar

Cuijpers, P, et al. Interpersonal psychotherapy for depression: A meta-analysis. American Journal of Psychiatry. 2011; 168(6): 581–592.Google Scholar

Weingarten, CP, Strauman, TJ. Neuroimaging for psychotherapy research: current trends. Psychotherapy Research. 2015; 25(2): 185–213.Google Scholar

Fournier, JC, Price, RB. Psychotherapy and neuroimaging. Focus. 2014; 12(3): 290–298.Google Scholar

Drevets, WC. Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Current opinion in neurobiology. 2001; 11(2): 240–249.CrossRef Google Scholar PubMed

Hariri, AR, Bookheimer, SY, Mazziotta, JC. Modulating emotional responses: Effects of a neocortical network on the limbic system. Neuroreport. 2000; 11(1): 43–48.Google Scholar

Fales, CL, et al. Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biological Psychiatry. 2008; 63(4): 377–384.Google Scholar

Vargas, C, Lopez-Jaramillo, C, Vieta, E. A systematic literature review of resting state network–functional MRI in bipolar disorder. J Affect Disord. 2013; 150(3): 727–735.Google Scholar

Radaelli, D, et al. Fronto-limbic disconnection in bipolar disorder. Eur Psychiatry. 2015; 30(1): 82–88.Google Scholar

Phillips, ML, Swartz, HA. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry. 2014; 171(8): 829–843.CrossRef Google Scholar

Siegle, GJ, Carter, CS, Thase, ME. Use of fMRI to predict recovery from unipolar depression with cognitive behavior therapy. American Journal of Psychiatry. 2006; 163(4): 735–738.Google Scholar

Yoshimura, S, et al. Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing. Social Cognitive and Affective Neuroscience. 2014; 9(4): 487–493.CrossRef Google Scholar PubMed

Ritchey, M, et al. Neural correlates of emotional processing in depression: Changes with cognitive behavioral therapy and predictors of treatment response. Journal of Psychiatric Research. 2011; 45(5): 577–587.Google Scholar

Fu, C, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biological Psychiatry. 2008; 64(6): 505–512.Google Scholar

Yoshimura, S, et al. Cognitive behavioral therapy changes functional connectivity between medial prefrontal and anterior cingulate cortices. Journal of Affective Disorders 2017; 208: 610–614.CrossRef Google Scholar PubMed

Assaf, M, et al. Neural functional architecture and modulation during decision making under uncertainty in individuals with generalized anxiety disorder. Brain Behav. 2018 August; 8(8): e01015.Google Scholar

Kennedy, SH, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry. 2007; 164(5): 778–788.CrossRef Google Scholar

Konarski, JZ, et al. Relationship between regional brain metabolism, illness severity and age in depressed subjects. Psychiatry Research: Neuroimaging. 2007; 155(3): 203–210.Google Scholar

Dichter, GS, Felder, JN, Smoski, MJ. The effects of brief behavioral activation therapy for depression on cognitive control in affective contexts: An fMRI investigation. Journal of Affective Disorders 2010; 126(1): 236–244.Google Scholar

Burgess, PW, Dumontheil, I, Gilbert, SI. The gateway hypothesis of rostral prefrontal cortex (area 10) function. Trends in Cognitive Sciences. 2007; 11(7): 290–298.Google Scholar

Wright, P, et al. Dissociated responses in the amygdala and orbitofrontal cortex to bottom–up and top–down components of emotional evaluation. Neuroimage. 2008; 39(2): 894–902.Google Scholar

Jollant, F, et al. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage 2010; 51(3): 1275–1281.Google Scholar

Fales, CL, et al. Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. Journal of Affective Disorders. 2009; 112(1–3): 206–211.Google Scholar

Harmer, CJ, et al. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biological Psychiatry. 2006; 59(9): 816–820.Google Scholar

Tiger, M, et al. Reduced 5-HT(1B) receptor binding in the dorsal brain stem after cognitive behavioural therapy of major depressive disorder. Psychiatry Res. 2014; 223(2): 164–170.Google Scholar

Goldapple, K, et al. Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy. Archives of General Psychiatry. 2004; 61(1): 34–41.Google Scholar

Brody, AL, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: Preliminary findings. Archives of General Psychiatry. 2001; 58(7): 631–640.Google Scholar

Martin, SD, et al. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: Preliminary findings. Archives of General Psychiatry. 2001; 58(7): 641–648.CrossRef Google Scholar PubMed

Sanacora, G, et al. Increased cortical GABA concentrations in depressed patients receiving ECT. American Journal of Psychiatry. 2003; 160(3): 577–579.Google Scholar

Sanacora, G, et al. Cortical γ-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biological Psychiatry 2006; 59(3): 284–286.Google Scholar

Abdallah, CG, et al. Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder. Psychother Psychosom. 2014; 83(5): 298–307.Google Scholar

Costafreda, SG, et al. Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport. 2009; 20(7): 637–641.Google Scholar

Siegle, GJ, et al. Toward clinically useful neuroimaging in depression treatment: Prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Archives of General Psychiatry. 2012; 69(9): 913–924.Google Scholar

Ressler, KJ. Amygdala activity, fear, and anxiety: Modulation by stress. Biological Psychiatry. 2010; 67(12): 1117–1119.Google Scholar

Dunlop, BW, et al. Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder. Am J Psychiatry. 2017; 174(6): 533–545.CrossRef Google Scholar PubMed

Thompson, DG, et al. fMRI activation during executive function predicts response to cognitive behavioral therapy in older, depressed adults. American Journal of Geriatric Psychiatry 2015; 23(1): 13–22.Google Scholar

Forbes, EE, et al. Reward-related brain function as a predictor of treatment response in adolescents with major depressive disorder. Cognitive, Affective, & Behavioral Neuroscience. 2010; 10(1): 107–118.Google Scholar

Fu, C, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy Biol Psychiatry. 2008; 64(6): 505–512.Google Scholar

Carl, H, et al. Sustained anterior cingulate cortex activation during reward processing predicts response to psychotherapy in major depressive disorder. J Affect Disord. 2016; 203: 204–212.Google Scholar

Dichter, GS, Felder, JN, Bodfish, JW. Autism is characterized by dorsal anterior cingulate hyperactivation during social target detection. Social Cognitive and Affective Neuroscience. 2009; 4(3): 215–226.Google Scholar

McGrath, CL, et al. Pretreatment brain states identify likely nonresponse to standard treatments for depression. Biological Psychiatry. 2014; 76(7): 527–535.Google Scholar

Konarski, JZ, et al. Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. Journal of Psychiatry & Neuroscience: JPN. 2009; 34(3): 175.Google Scholar

Seminowicz, D, et al. Limbic–frontal circuitry in major depression: A path modeling metanalysis. Neuroimage. 2004; 22(1): 409–418.Google Scholar

Critchley, HD, et al. Neural systems supporting interoceptive awareness. Nature Neuroscience. 2004; 7(2): 189.CrossRef Google Scholar PubMed

Fujino, J, et al. Anterior cingulate volume predicts response to cognitive behavioral therapy in major depressive disorder. J Affect Disord. 2015; 174: 397–399.Google Scholar

Sambataro, F, et al. Anterior cingulate volume predicts response to psychotherapy and functional connectivity with the inferior parietal cortex in major depressive disorder. Eur Neuropsychopharmacol. 2018; 28(1): 138–148.Google Scholar

Pizzagalli, DA. Frontocingulate dysfunction in depression: Toward biomarkers of treatment response. Neuropsychopharmacology. 2011; 36(1): 183.Google Scholar

Burkhouse, KL, et al. Neural reactivity to reward as a predictor of cognitive behaviroal therapy response in anxiety and depression. Depress Anxiety. 2016; 33(4): 281–288.Google Scholar

DeRubeis, RJ, Strunk, DR. The Oxford Handbook of Mood Disorders. Oxford University Press; 2017.Google Scholar

Salvadore, G, et al. Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology. 2010; 35(7): 1415.Google Scholar

Keedwell, P, et al. Neural markers of symptomatic improvement during antidepressant therapy in severe depression: Subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. Journal of Psychopharmacology 2009; 23(7): 775–788.Google Scholar

Weigand, A, et al. Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites. Biological Psychiatry. 2018; 84(1): 28–37.CrossRef Google Scholar PubMed

Wu, J, et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. American Journal of Psychiatry. 1999; 156(8): 1149–1158.Google Scholar

Kringelbach, ML, Rolls, ET. The functional neuroanatomy of the human orbitofrontal cortex: Evidence from neuroimaging and neuropsychology. Progress in Neurobiology. 2004; 72(5): 341–372.Google Scholar

Kurth, F, et al. A link between the systems: Functional differentiation and integration within the human insula revealed by meta-analysis. Brain Structure and Function. 2010; 214(5–6): 519–534.Google Scholar

van der Werff, SJ, et al. Neuroimaging resilience to stress: A review. Frontiers in Behavioral Neuroscience. 2013; 7: 39.Google Scholar

Drevets, WC, Price, JL, Furey, ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function. 2008; 213(1–2): 93–118.Google Scholar

Shin, LM, Liberzon, I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010; 35(1): 169.Google Scholar